Advanced Heart Failure and Transplant Cardiology · Houma, LA
NPI
1437156429
Since 2005
Specialty
Advanced Heart Failure and Transplant Cardiology
Code 207RA0001X
Group practices
3
Medicare group memberships
Hospitals
5
Hospital affiliations
225 Dunn St
Houma, LA, 70360
Phone (985) 876-0300
Groups this clinician bills Medicare through
Medicare paid, 2024
$486K
48,655 services
Medicare patients, 2024
1,137
Average age 76
Drug cost, 2024
$3.7M
15,830 prescriptions
Company payments, 2025
$10K
From 17 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Peter S Fail was code Q9967 (low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml), 38,576 times for 347 patients. In total Peter S Fail billed 48,655 services in 142 codes, and Medicare paid $486K.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2018-07-05.
| Code |
|---|
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | Office | 38,576 | 347 | $0.10 | $4,013 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 1,139 | 654 | $11.70 | $13K |
| 99214 Office E&M - Established | Office | 985 | 636 | $82.90 | $82K |
| 80061 Clinical Chemistry | Office | 688 | 448 | $13.07 | $8,992 |
| 84460 Clinical Chemistry | Office | 600 | 380 | $5.18 | $3,106 |
| 84450 Clinical Chemistry | Office | 599 | 379 | $5.07 | $3,039 |
| 84075 Clinical Chemistry | Office | 598 | 379 | $5.07 | $3,034 |
| 83880 Clinical Chemistry | Office | 399 | 248 | $38.42 | $15K |
| 80048 Clinical Chemistry | Office | 364 | 239 | $8.27 | $3,011 |
| 99490 Chronic, Principal, and Transitional Care Management | Office | 354 | 40 | $42.41 | $15K |
| 93000 Electrocardiogram | Office | 336 | 248 | $9.78 | $3,286 |
| 85027 Blood Count | Office | 264 | 209 | $6.30 | $1,663 |
| 93306 Echocardiography (TTE/TEE) | Office | 261 | 237 | $126.69 | $33K |
| 99454 E&M - Miscellaneous | Office | 230 | 33 | $29.10 | $6,693 |
| 99457 E&M - Miscellaneous | Office | 206 | 34 | $32.30 | $6,654 |
By year: 2022 $440K for 22,222 services; 2023 $409K for 27,437 services; 2024 $486K for 48,655 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 80061 Clinical Chemistry | 688 | 448 | $13.07 | $8,992 |
| 84460 Clinical Chemistry | 600 | 380 | $5.18 | $3,106 |
| 84450 Clinical Chemistry | 599 | 379 | $5.07 | $3,039 |
| 84075 Clinical Chemistry | 598 | 379 | $5.07 | $3,034 |
| 83880 Clinical Chemistry | 399 | 248 | $38.42 | $15K |
| 80048 Clinical Chemistry | 364 | 239 | $8.27 | $3,011 |
| 85027 Blood Count | 264 | 209 | $6.30 | $1,663 |
| 80053 Clinical Chemistry | 201 | 166 | $10.26 | $2,062 |
| 84436 Clinical Chemistry | 108 | 100 | $6.73 | $727 |
| 84479 Clinical Chemistry | 108 | 100 | $6.34 | $685 |
Medicare prescription drug claims, 2024
In 2024, the drug Peter S Fail prescribed most often to Medicare patients was Atorvastatin Calcium, with 1,295 prescriptions and refills. In total Peter S Fail wrote 15,830 Medicare prescriptions that cost $3.7M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Atorvastatin Calcium Generic | 1,295 | 3,567 | 362 | $14K |
| Rosuvastatin Calcium Generic | 1,278 | 3,451 | 376 | $18K |
| Metoprolol Succinate Generic | 1,274 | 3,377 | 369 | $17K |
| Ezetimibe Generic | 907 | 2,283 | 244 | $16K |
| Jardiance Empagliflozin | 904 | 1,599 | 223 | $919K |
| Clopidogrel Clopidogrel Bisulfate | 716 | 1,718 | 216 | $6,626 |
| Amlodipine Besylate Generic | 700 | 1,847 | 214 | $4,331 |
| Valsartan Generic | 689 | 1,790 | 209 | $18K |
| Entresto Sacubitril/Valsartan | 674 | 1,224 | 180 | $791K |
| Spironolactone Generic | 659 | 1,654 | 215 | $3,936 |
| Eliquis Apixaban | 423 | 754 | 110 | $429K |
| Furosemide Generic | 374 | 846 | 113 | $1,543 |
| Carvedilol Generic | 302 | 719 | 83 | $2,798 |
| Doxazosin Mesylate Generic | 290 | 800 | 84 | $3,286 |
| Isosorbide Mononitrate Er Isosorbide Mononitrate | 259 | 650 | 64 | $3,018 |
Brand drugs: 3,063 claims; generic drugs: 12,767 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Peter S Fail $10K ($10K in general payments such as food, travel and fees) from 17 companies. The largest payer was Medtronic, Inc. with $4,087.
| Company | Payments | Amount |
|---|---|---|
| Medtronic, Inc. MDT | 30 | $4,087 |
| Edwards Lifesciences Corporation EW | 35 | $3,366 |
| Abbott Laboratories ABT | 10 | $1,541 |
| Ancora Heart, Inc. | 4 | $435 |
| E.R. Squibb & Sons, L.L.C. BMY | 8 | $186 |
| Abiomed JNJ | 2 | $179 |
| AngioDynamics, Inc. ANGO | 2 | $166 |
| Terumo Medical Corporation | 2 | $120 |
| Penumbra, Inc. PEN | 1 | $100 |
| Merck Sharp & Dohme LLC MRK | 1 | $91.36 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.